Recent Finacing
Recent Raise
ImmunoFree develops stem-cell-based transplant therapies to induce immune tolerance and enable durable organ acceptance without chronic immunosuppression, focusing on R&D, commercialization, and improved access for underserved patients.
Focus Areas
Recent Investors
Funding round
Investor